Status:
UNKNOWN
COVID-19 Infection in Diabetic Patients
Lead Sponsor:
Cairo University
Conditions:
Covid19
Diabete Type 2
Eligibility:
All Genders
30+ years
Brief Summary
It was observed during the last period of COVID-19 pandemic that diabetic patients had a worse prognosis and more deteriorated clinical features than other patients
Detailed Description
Diabetic patients infected with SAR-COV-19 were reported to have worse prognosis and faster deterioration in addition to higher rate for ICU admission when compared to other infected patients. In this...
Eligibility Criteria
Inclusion
- Patients infected with COVID-19 male or female 30 years old or more inpatients
Exclusion
- have othe comorbidities other than type 2 diabetes mellitus pregnant women below 30 years old
Key Trial Info
Start Date :
February 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 10 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04765254
Start Date
February 20 2021
End Date
April 10 2021
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University teaching hospitals
Cairo, Kasr Al Ainy, Egypt, 11311